|
|
| | Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- Basic information |
| | Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- Chemical Properties |
| | Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- Usage And Synthesis |
| Uses | Rosuvastatin zinc salt (Rosuvastatin zinc) is a zinc-containing form of Rosuvastatin (HY-17504A). Rosuvastatin is a HMG-CoA reductase inhibitor and can be used for atherosclerosis research[1]. | | References | [1] Watanabe M, et al. Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem. 1997 Feb;5(2):437-44. DOI:10.1016/s0968-0896(96)00248-9 |
| | Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- Preparation Products And Raw materials |
|